{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["AIDS", "HAART", "HIV", "POM", "coumarin", "reverse transcriptase", "synthesis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "38004404", "DateRevised": {"Year": "2023", "Month": "11", "Day": "27"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "10", "Day": "31"}], "Language": ["eng"], "ELocationID": ["1538", "10.3390/ph16111538"], "Journal": {"ISSN": "1424-8247", "JournalIssue": {"Volume": "16", "Issue": "11", "PubDate": {"Year": "2023", "Month": "Oct", "Day": "31"}}, "Title": "Pharmaceuticals (Basel, Switzerland)", "ISOAbbreviation": "Pharmaceuticals (Basel)"}, "ArticleTitle": "Recent Progress in Synthesis, POM Analyses and SAR of Coumarin-Hybrids as Potential Anti-HIV Agents-A Mini Review.", "Abstract": {"AbstractText": ["The human immunodeficiency virus (HIV) is the primary cause of acquired immune deficiency syndrome (AIDS), one of the deadliest pandemic diseases. Various mechanisms and procedures have been pursued to synthesise several anti-HIV agents, but due to the severe side effects and multidrug resistance spawning from the treatment of HIV/AIDS using highly active retroviral therapy (HAART), it has become imperative to design and synthesise novel anti-HIV agents. Literature has shown that natural sources, particularly the plant kingdom, can release important metabolites that have several biological, mechanistic and structural representations similar to chemically synthesised compounds. Certainly, compounds from natural and ethnomedicinal sources have proven to be effective in the management of HIV/AIDS with low toxicity, fewer side effects and affordability. From plants, fungi and bacteria, coumarin can be obtained, which is a secondary metabolite and is well known for its actions in different stages of the HIV replication cycle: protease, integrase and reverse transcriptase (RT) inhibition, cell membrane fusion and viral host attachment. These, among other reasons, are why coumarin moieties will be the basis of a good building block for the development of potent anti-HIV agents. This review aims to outline the synthetic pathways, structure-activity relationship (SAR) and POM analyses of coumarin hybrids with anti-HIV activity, detailing articles published between 2000 and 2023."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Faculty of Science, Universiti Teknologi Malaysia, Johor Bahru 81310, Johor, Malaysia."}, {"Identifier": [], "Affiliation": "Department of Chemistry, Sokoto State University, Birnin Kebbi Road, Sokoto 852101, Nigeria."}], "LastName": "Suleiman", "ForeName": "Mustapha", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Umm Al-Qura University, Mecca 21955, Saudi Arabia."}], "LastName": "Almalki", "ForeName": "Faisal A", "Initials": "FA"}, {"Identifier": ["0000-0002-5633-6203"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Umm Al-Qura University, Mecca 21955, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Laboratory of Applied Chemistry & Environment, Faculty of Sciences, Mohammed Premier University, MB 524, Oujda 60000, Morocco."}], "LastName": "Ben Hadda", "ForeName": "Taibi", "Initials": "T"}, {"Identifier": ["0000-0001-7964-9117"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Carbohydrate and Nucleoside Chemistry, Department of Chemistry, University of Chittagong, Chittagong 4331, Bangladesh."}], "LastName": "Kawsar", "ForeName": "Sarkar M A", "Initials": "SMA"}, {"Identifier": ["0000-0003-1244-2466"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Amity Institute of Phytochemistry & Phytomedicine, Amity University Uttar Pradesh, Noida 201313, India."}], "LastName": "Chander", "ForeName": "Subhash", "Initials": "S"}, {"Identifier": ["0000-0002-3680-1577"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Chemistry Research Laboratory, Birla Institute of Technology & Science Pilani (BITS Pilani), Pilani Campus, Pilani 333031, India."}], "LastName": "Murugesan", "ForeName": "Sankaranarayanan", "Initials": "S"}, {"Identifier": ["0000-0003-4751-8379"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, R.T.M. Nagpur University, Nagpur 440033, India."}], "LastName": "Bhat", "ForeName": "Ajmal R", "Initials": "AR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research and Production Center for Microbiology and Virology, Almaty 050010, Kazakhstan."}], "LastName": "Bogoyavlenskiy", "ForeName": "Andrey", "Initials": "A"}, {"Identifier": ["0000-0002-1756-7244"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Faculty of Science, Universiti Teknologi Malaysia, Johor Bahru 81310, Johor, Malaysia."}], "LastName": "Jamalis", "ForeName": "Joazaizulfazli", "Initials": "J"}], "GrantList": [{"GrantID": "BR10965178", "Agency": "Ministry of Education and Science of the Republic of Kazakhstan", "Country": ""}, {"GrantID": "FRGS/1/2022/STG04/UTM/02/4", "Agency": "Ministry of Higher Education (MOHE) Malaysia", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceuticals (Basel)", "NlmUniqueID": "101238453", "ISSNLinking": "1424-8247"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Mohamed H., Gurrola T., Berman R., Collins M., Sariyer I.K., Nonnemacher M.R., Wigdahl B. Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy. Front. Immunol. 2022;12:816515. doi: 10.3389/fimmu.2021.816515.", "ArticleIdList": ["10.3389/fimmu.2021.816515", "PMC8811197", "35126374"]}, {"Citation": "Yu D., Suzuki M., Xie L., Morris-natschke S.L., Lee K. Recent Progress in the Development of Coumarin Derivatives as Potent. Med. Res. Rev. 2003;23:322\u2013345. doi: 10.1002/med.10034.", "ArticleIdList": ["10.1002/med.10034", "12647313"]}, {"Citation": "Kumar V., Joshi H.C., Pandey I.P. Reverse Transcriptase Inhibition: A Way to Defeat HIV. HIV AIDS Rev. 2022;21:3\u20139. doi: 10.5114/hivar.2022.112762.", "ArticleIdList": ["10.5114/hivar.2022.112762"]}, {"Citation": "Xu Z., Chen Q., Zhang Y., Liang C. Coumarin-Based Derivatives with Potential Anti-HIV Activity. Fitoterapia. 2021;150:104863. doi: 10.1016/j.fitote.2021.104863.", "ArticleIdList": ["10.1016/j.fitote.2021.104863", "33582266"]}, {"Citation": "Tariq M., Sirajuddin M., Ali S., Khalid N., Tahir M.N., Khan H., Ansari T.M. Pharmacological Investigations and Petra/Osiris/Molinspiration (POM) Analyses of Newly Synthesized Potentially Bioactive Organotin(IV) Carboxylates. J. Photochem. Photobiol. B. 2016;158:174\u2013183. doi: 10.1016/j.jphotobiol.2016.02.028.", "ArticleIdList": ["10.1016/j.jphotobiol.2016.02.028", "26974578"]}, {"Citation": "Suleiman M., Hasan A.H., Murugesan S., Amran S.I., Jamalis J. Advances in the Synthesis of Diarylpyrimidine as Potent Non-Nucleoside Reverse Transcriptase Inhibitors: Biological Activities, Molecular Docking Studies and Structure-Activity Relationship: A Critical Review. Curr. Org. Chem. 2023;27:661\u2013691. doi: 10.2174/1385272827666230711173329.", "ArticleIdList": ["10.2174/1385272827666230711173329"]}, {"Citation": "Falagas M.E., Pitsouni E.I., Malietzis G.A., Pappas G. Comparison of PubMed, Scopus, Web of Science, and Google Scholar: Strengths and Weaknesses. FASEB J. 2008;22:338\u2013342. doi: 10.1096/fj.07-9492LSF.", "ArticleIdList": ["10.1096/fj.07-9492LSF", "17884971"]}, {"Citation": "Cunningham W.E., Tisnado D.M., Hu Lui H., Nakazono T.T., Carlisle D.M. The Effect of Hospital Experience on Mortality among Patients Hospitalized with Acquired Immunodeficiency Syndrome in California. Am. J. Med. 1999;107:137\u2013143. doi: 10.1016/S0002-9343(99)00195-3.", "ArticleIdList": ["10.1016/S0002-9343(99)00195-3", "10460044"]}, {"Citation": "Kitahata M.M., Koepsell T.D., Deyo R.A., Maxwell C.L., Dodge W.T., Wagner E.H. Physicians\u2019 Experience with the Acquired Immunodeficiency Syndrome as a Factor in Patients\u2019 Survival. N. Engl. J. Med. 1996;334:701\u2013707. doi: 10.1056/NEJM199603143341106.", "ArticleIdList": ["10.1056/NEJM199603143341106", "8594430"]}, {"Citation": "Olomola T.O., Klein R., Mautsa N., Sayed Y., Kaye P.T. Synthesis and Evaluation of Coumarin Derivatives as Potential Dual-Action HIV-1 Protease and Reverse Transcriptase Inhibitors. Bioorg. Med. Chem. 2013;21:1964\u20131971. doi: 10.1016/j.bmc.2013.01.025.", "ArticleIdList": ["10.1016/j.bmc.2013.01.025", "23415084"]}, {"Citation": "Thompson M.A., Aberg J.A., Hoy J.F., Telenti A., Benson C., Cahn P., Eron J.J., G\u00fc Nthard H.F., Hammer S.M., Reiss P., et al. Antiretroviral Treatment of Adult HIV Infection 2012 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2012;308:387\u2013402. doi: 10.1001/jama.2012.7961.", "ArticleIdList": ["10.1001/jama.2012.7961", "22820792"]}, {"Citation": "Post F.A., Moyle G.J., Stellbrink H.J., Domingo P., Podzamczer D., Fisher M., Norden A.G., Cavassini M., Rieger A., Khuong-Josses M.-A., et al. Randomized Comparison of Renal Effects, Efficacy, and Safety with Once-Daily Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Administered with Efavirenz, in Antiretroviral-Naive, HIV-1-Infected Adults: 48-Week Results from the ASSERT Study. J. Acquir. Immune Defic. Syndr. 2010;55:49\u201357. doi: 10.1097/QAI.0b013e3181dd911e.", "ArticleIdList": ["10.1097/QAI.0b013e3181dd911e", "20431394"]}, {"Citation": "G\u00fcnthard H.F., Saag M.S., Benson C.A., Del Rio C., Eron J.J., Gallant J.E., Hoy J.F., Mugavero M.J., Sax P.E., Thompson M.A., et al. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel. JAMA\u2014J. Am. Med. Assoc. 2016;316:191\u2013210. doi: 10.1001/jama.2016.8900.", "ArticleIdList": ["10.1001/jama.2016.8900", "PMC5012643", "27404187"]}, {"Citation": "Rodger A.J., Cambiano V., Bruun T., Vernazza P., Collins S., Van Lunzen J., Corbelli G.M., Estrada V., Geretti A.M., Beloukas A., et al. Sexual Activity without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy. JAMA\u2014J. Am. Med. Assoc. 2016;316:171\u2013181. doi: 10.1001/jama.2016.5148.", "ArticleIdList": ["10.1001/jama.2016.5148", "27404185"]}, {"Citation": "Read P.J., Mandalia S., Khan P., Harrisson U., Naftalin C., Gilleece Y., Anderson J., Hawkins D.A., Taylor G.P., De Ruiter A. When Should HAART Be Initiated in Pregnancy to Achieve an Undetectable HIV Viral Load by Delivery? AIDS. 2012;26:1095\u20131103. doi: 10.1097/QAD.0b013e3283536a6c.", "ArticleIdList": ["10.1097/QAD.0b013e3283536a6c", "22441248"]}, {"Citation": "Hoffman R.M., Black V. Effects of Highly Active Antiretroviral Therapy Duration and Regimen on Risk for Mother-to-Child Transmission of HIV in Johannesburg, South Africa. J. Acquir. Immune Defic. Syndr. 2010;54:35\u201341. doi: 10.1097/QAI.0b013e3181cf9979.", "ArticleIdList": ["10.1097/QAI.0b013e3181cf9979", "PMC2880466", "20216425"]}, {"Citation": "Forbes J.C., Alimenti A.M., Singer J., Brophy J.C., Bitnun A., Samson L.M., Money D.M., Lee T.C.K., Lapointe N.D., Read S.E. A National Review of Vertical HIV Transmission. AIDS. 2012;26:757\u2013763. doi: 10.1097/QAD.0b013e328350995c.", "ArticleIdList": ["10.1097/QAD.0b013e328350995c", "22210635"]}, {"Citation": "Est\u00e9 J.A., Cihlar T. Current Status and Challenges of Antiretroviral Research and Therapy. Antivir. Res. 2010;85:25\u201333. doi: 10.1016/j.antiviral.2009.10.007.", "ArticleIdList": ["10.1016/j.antiviral.2009.10.007", "20018390"]}, {"Citation": "Li Z., Kong D., Liu Y., Li M. Pharmacological Perspectives and Molecular Mechanisms of Coumarin Derivatives against Virus Disease. Genes Dis. 2022;9:80\u201394. doi: 10.1016/j.gendis.2021.03.007.", "ArticleIdList": ["10.1016/j.gendis.2021.03.007", "PMC8720699", "35005109"]}, {"Citation": "World Health Assembly  42 Forty-Second World Health Assembly, Geneva, 8\u201319 May 1989: Resolutions and Decisions, Annexes. 1989.  [(accessed on 3 June 2022)].  Available online:  https://apps.who.int/iris/handle/10665/171211."}, {"Citation": "World Health Organization; Onchocerciasis Control Programme in West Africa. Progress Report of the World Health Organization for 1989 (1 September 1988\u201331 August 1989); Onchocerciasis Control Programme in West Africa, 1989.  [(accessed on 3 June 2022)].  Available online:  https://apps.who.int/iris/handle/10665/345231."}, {"Citation": "Annunziata F., Pinna C., Dallavalle S., Tamborini L., Pinto A. An Overview of Coumarin as a Versatile and Readily Accessible Scaffold with Broad-Ranging Biological Activities. Int. J. Mol. Sci. 2020;21:4618. doi: 10.3390/ijms21134618.", "ArticleIdList": ["10.3390/ijms21134618", "PMC7370201", "32610556"]}, {"Citation": "Borges F., Roleira F., Milhazes N., Santana L., Uriarte E. Simple Coumarins and Analogues in Medicinal Chemistry: Occurrence, Synthesis and Biological Activity. Curr. Med. Chem. 2005;12:887\u2013916. doi: 10.2174/0929867053507315.", "ArticleIdList": ["10.2174/0929867053507315", "15853704"]}, {"Citation": "Krogsgaard Thomsen M., Bokvist K., H\u00f8y M., Buschard K., Holst J.J., Lindstr\u00f6m P., Gromada J. Repaglinide at a Cellular Level. Diabetes Nutr. Metab. 2002;15:15\u201318.", "ArticleIdList": ["12702003"]}, {"Citation": "Hasan A.H., Murugesan S., Amran S.I., Chander S., Alanazi M.M., Ben Hadda T., Shakya S., Pratama M.R.F., Das B., Biswas S., et al. Novel Thiophene Chalcones-Coumarin as Acetylcholinesterase Inhibitors: Design, Synthesis, Biological Evaluation, Molecular Docking, ADMET Prediction and Molecular Dynamics Simulation. Bioorg. Chem. 2022;119:105572. doi: 10.1016/j.bioorg.2021.105572.", "ArticleIdList": ["10.1016/j.bioorg.2021.105572", "34971946"]}, {"Citation": "Ramli N., Mohd Sobani S.S. Jurnal Teknologi. J. Teknol. 2013;2:19\u201325."}, {"Citation": "Tang T., Liu J., Zuo K., Cheng J., Chen L., Lu C., Han S., Xu J., Jia Z., Ye M., et al. Genotype-Guided Dosing of Coumarin Anticoagulants: A Meta-Analysis of Randomized Controlled Trials. J. Cardiovasc. Pharmacol. Ther. 2015;20:387\u2013394. doi: 10.1177/1074248414565666.", "ArticleIdList": ["10.1177/1074248414565666", "25575537"]}, {"Citation": "Jumal J. Norhanis Sakinah Synthesis, Characterization, and Applications of Coumarin Derivatives: A Short Review. Malays. J. Sci. Health Technol. 2021;7:62\u201368. doi: 10.33102/mjosht.v7i1.145.", "ArticleIdList": ["10.33102/mjosht.v7i1.145"]}, {"Citation": "Song M.Q., Min W., Wang J., Si X.X., Wang X.J., Liu Y.W., Shi D.H. Design, Synthesis and Biological Evaluation of New Carbazole-Coumarin Hybrids as Dual Binding Site Inhibitors of Acetylcholinesterase. J. Mol. Struct. 2021;1229:129784. doi: 10.1016/j.molstruc.2020.129784.", "ArticleIdList": ["10.1016/j.molstruc.2020.129784"]}, {"Citation": "Srivastav V.K., Tiwari M. QSAR and Docking Studies of Coumarin Derivatives as Potent HIV-1 Integrase Inhibitors. Arab. J. Chem. 2017;10:S1081\u2013S1094. doi: 10.1016/j.arabjc.2013.01.015.", "ArticleIdList": ["10.1016/j.arabjc.2013.01.015"]}, {"Citation": "Singh V.K., Srivastava R., Gupta P.S.S., Naaz F., Chaurasia H., Mishra R., Rana M.K., Singh R.K. Anti-HIV Potential of Diarylpyrimidine Derivatives as Non-Nucleoside Reverse Transcriptase Inhibitors: Design, Synthesis, Docking, TOPKAT Analysis and Molecular Dynamics Simulations. J. Biomol. Struct. Dyn. 2021;39:2430\u20132446. doi: 10.1080/07391102.2020.1748111.", "ArticleIdList": ["10.1080/07391102.2020.1748111", "32216610"]}, {"Citation": "Reddy D.S., Kongot M., Kumar A. Coumarin Hybrid Derivatives as Promising Leads to Treat Tuberculosis: Recent Developments and Critical Aspects of Structural Design to Exhibit Anti-Tubercular Activity. Tuberculosis. 2021;127:102050. doi: 10.1016/j.tube.2020.102050.", "ArticleIdList": ["10.1016/j.tube.2020.102050", "33540334"]}, {"Citation": "Hu Y.Q., Xu Z., Zhang S., Wu X., Ding J.W., Lv Z.S., Feng L.S. Recent Developments of Coumarin-Containing Derivatives and Their Anti-Tubercular Activity. Eur. J. Med. Chem. 2017;136:122\u2013130. doi: 10.1016/j.ejmech.2017.05.004.", "ArticleIdList": ["10.1016/j.ejmech.2017.05.004", "28494250"]}, {"Citation": "Gao P., Song S., Wang Z., Sun L., Zhang J., Pannecouque C., de Clercq E., Zhan P., Liu X. Design, Synthesis and Anti-HIV Evaluation of Novel 5-Substituted Diarylpyrimidine Derivatives as Potent HIV-1 NNRTIs. Bioorg. Med. Chem. 2021;40:116195. doi: 10.1016/j.bmc.2021.116195.", "ArticleIdList": ["10.1016/j.bmc.2021.116195", "33979774"]}, {"Citation": "Rojekar S., Fotooh Abadi L., Pai R., Mahajan K., Kulkarni S., Vavia P.R. Multi-Organ Targeting of HIV-1 Viral Reservoirs with Etravirine Loaded Nanostructured Lipid Carrier: An in vivo Proof of Concept. Eur. J. Pharm. Sci. 2021;164:105916. doi: 10.1016/j.ejps.2021.105916.", "ArticleIdList": ["10.1016/j.ejps.2021.105916", "34166780"]}, {"Citation": "Jashari A., Hey-Hawkins E., Mikhova B., Draeger G., Popovski E. An Improved Synthesis of 4-Chlorocoumarin-3-Sulfonyl Chloride and Its Reactions with Different Bidentate Nucleophiles to Give Pyrido[1\u2032,2\u2032:2,3]- and Thiazino[3\u2032,2\u2032:2,3]-1,2,4-Thiadiazino[6,5-c]Benzopyran-6-One 7,7-Dioxides. Molecules. 2007;12:2017\u20132028. doi: 10.3390/12082017.", "ArticleIdList": ["10.3390/12082017", "PMC6149111", "17960102"]}, {"Citation": "Wadhwa P., Jain P., Rudrawar S., Jadhav H.R.A. Quinoline, Coumarin and Other Heterocyclic Analogs Based HIV-1 Integrase Inhibitors. Curr. Drug Discov. Technol. 2017;15:2\u201319. doi: 10.2174/1570163814666170531115452.", "ArticleIdList": ["10.2174/1570163814666170531115452", "28558629"]}, {"Citation": "Mishra S., Pandey A., Manvati S. Coumarin: An Emerging Antiviral Agent. Heliyon. 2020;6:e03217. doi: 10.1016/j.heliyon.2020.e03217.", "ArticleIdList": ["10.1016/j.heliyon.2020.e03217", "PMC7002824", "32042967"]}, {"Citation": "Al-Soud Y.A., Al-Masoudi I.A., Saeed B., Beifu\u00df U., Al-Masoudi N.A. Synthesis of New 1H-1,2,4-Triazolylcoumarins and Their Antitumor and Anti-HIV Activities. Chem. Heterocycl. Compd. 2006;42:583\u2013590. doi: 10.1007/s10593-006-0130-2.", "ArticleIdList": ["10.1007/s10593-006-0130-2"]}, {"Citation": "Kumar S., Khokra S.L., Yadav A. Triazole Analogues as Potential Pharmacological Agents: A Brief Review. Future J. Pharm. Sci. 2021;7:106. doi: 10.1186/s43094-021-00241-3.", "ArticleIdList": ["10.1186/s43094-021-00241-3", "PMC8148872", "34056014"]}, {"Citation": "Jebir R.M., Mustafa Y.F. Natural Coumarin-Lead Compounds: A Review of Their Medicinal Potentials. Iraqi J. Pharm. 2022;18:139\u2013161. doi: 10.33899/iphr.2022.170404.", "ArticleIdList": ["10.33899/iphr.2022.170404"]}, {"Citation": "Trivedi J.C., Bariwal J.B., Upadhyay K.D., Naliapara Y.T., Joshi S.K., Pannecouque C.C., de Clercq E., Shah A.K. Improved and Rapid Synthesis of New Coumarinyl Chalcone Derivatives and Their Antiviral Activity. Tetrahedron Lett. 2007;48:8472\u20138474. doi: 10.1016/j.tetlet.2007.09.175.", "ArticleIdList": ["10.1016/j.tetlet.2007.09.175"]}, {"Citation": "Patel R.B., Chikhalia K.H., Pannecouque C., de Clercq E. Synthesis of Novel PETT Analogues: 3,4-Dimethoxy Phenyl Ethyl 1,3,5-Triazinyl Thiourea Derivatives and Their Antibacterial and Anti-HIV Studies. J. Braz. Chem. Soc. 2007;18:312\u2013321. doi: 10.1590/S0103-50532007000200011.", "ArticleIdList": ["10.1590/S0103-50532007000200011"]}, {"Citation": "Reddy Y.T., Reddy P.N., Crooks P.A., De Clercq E., Rao G.V.P., Rajitha B. Synthesis and biological evaluation of novel substituted n1-[1-benzyl-3-(3-tert-butylcarbamoyl-octahydroisoquinolin-2yl)-2-hydroxy-propyl]-2-[(2-oxo-2h-chromene-3-carbonyl) amino] succinamide analogs as \u03b1\u03bd\u03c4\u03b9-viral and \u03b1\u03bd\u03c4\u03b9-hiv agents. Heterocycl. Commun. 2008;14:419\u2013426. doi: 10.1515/HC.2008.14.6.419.", "ArticleIdList": ["10.1515/HC.2008.14.6.419"]}, {"Citation": "Al-Soud Y.A., Al-Sa\u2019doni H.H., Amajaour H.A.S., Salih K.S.M., Mubarak M.S., Al-Masoudi N.A., Jaber I.H. Synthesis, Characterization and Anti-HIV and Antitumor Activities of New Coumarin Derivatives. Z. Naturforschung B. 2008;63:83\u201389. doi: 10.1515/znb-2008-0112.", "ArticleIdList": ["10.1515/znb-2008-0112"]}, {"Citation": "Al-Masoudi N.A., Pfleiderer W., Pannecouque C. Nitroimidazoles Part 7. Synthesis and Anti-HIV Activity of New 4-Nitroimidazole Derivatives. Z. Naturforschung-Sect. B J. Chem. Sci. 2012;67:835\u2013842. doi: 10.5560/znb.2012-0122.", "ArticleIdList": ["10.5560/znb.2012-0122"]}, {"Citation": "Al-Soud Y.A., Al-Masoudi N.A., de Clercq E., Paneccoque C. Nitroimidazoles, Part 4: Synthesis and Anti-HIV Activity of New 5-Alkylsulfanyl and 5-(4\u2032-Arylsulfonyl)Piperazinyl-4-Nitroimidazole Derivatives. Heteroat. Chem. 2007;18:333\u2013340. doi: 10.1002/hc.20301.", "ArticleIdList": ["10.1002/hc.20301"]}, {"Citation": "Jorgensen W.L. Efficient Drug Lead Discovery and Optimization. Acc. Chem. Res. 2009;42:724\u2013733. doi: 10.1021/ar800236t.", "ArticleIdList": ["10.1021/ar800236t", "PMC2727934", "19317443"]}, {"Citation": "Mahajan D.H., Pannecouque C., de Clercq E., Chikhalia K.H. Synthesis and Studies of New 2-(Coumarin-4-Yloxy)-4,6-(Substituted)-s- Triazine Derivatives as Potential Anti-HIV Agents. Arch. Pharm. 2009;342:281\u2013290. doi: 10.1002/ardp.200800149.", "ArticleIdList": ["10.1002/ardp.200800149", "19415671"]}, {"Citation": "Olomola T.O., Klein R., Lobb K.A., Sayed Y., Kaye P.T. Towards the Synthesis of Coumarin Derivatives as Potential Dual-Action HIV-1 Protease and Reverse Transcriptase Inhibitors. Tetrahedron Lett. 2010;51:6325\u20136328. doi: 10.1016/j.tetlet.2010.09.121.", "ArticleIdList": ["10.1016/j.tetlet.2010.09.121"]}, {"Citation": "Livani Z.A., Safakish M., Hajimahdi Z., Soleymani S., Zabihollahi R., Aghasadeghi M.R., Alipour E., Zarghi A. Design, Synthesis, Molecular Modeling, In Silico ADME Studies and Anti-HIV-1 Assay of New Diazocoumarin Derivatives. Iran J. Pharm. Res. 2018;17:65\u201377. doi: 10.22037/ijpr.2018.2376.", "ArticleIdList": ["10.22037/ijpr.2018.2376", "PMC6447871", "31011343"]}, {"Citation": "Jesumoroti O.J., Faridoon, Mnkandhla D., Isaacs M., Hoppe H.C., Klein R. Evaluation of Novel N\u2032-(3-Hydroxybenzoyl)-2-Oxo-2H-Chromene-3-Carbohydrazide Derivatives as Potential HIV-1 Integrase Inhibitors. Medchemcomm. 2019;10:80\u201388. doi: 10.1039/C8MD00328A.", "ArticleIdList": ["10.1039/C8MD00328A", "PMC6350760", "30774857"]}, {"Citation": "Esposito F., Ambrosio F.A., Maleddu R., Costa G., Rocca R., Maccioni E., Catalano R., Romeo I., Eleftheriou P., Karia D.C., et al. Chromenone Derivatives as a Versatile Scaffold with Dual Mode of Inhibition of HIV-1 Reverse Transcriptase-Associated Ribonuclease H Function and Integrase Activity. Eur. J. Med. Chem. 2019;182:111617. doi: 10.1016/j.ejmech.2019.111617.", "ArticleIdList": ["10.1016/j.ejmech.2019.111617", "31442684"]}, {"Citation": "Zhu M., Ma L., Wen J., Dong B., Wang Y., Wang Z., Zhou J., Zhang G., Wang J., Guo Y., et al. Rational Design and Structure\u2212Activity Relationship of Coumarin Derivatives Effective on HIV-1 Protease and Partially on HIV-1 Reverse Transcriptase. Eur. J. Med. Chem. 2020;186:111900. doi: 10.1016/j.ejmech.2019.111900.", "ArticleIdList": ["10.1016/j.ejmech.2019.111900", "31771827"]}, {"Citation": "Maly D.J., Leonetti F., Backes B.J., Dauber D.S., Harris J.L., Craik C.S., Ellman J.A. Expedient Solid-Phase Synthesis of Fluorogenic Protease Substrates Using the 7-Amino-4-Carbamoylmethylcoumarin (ACC) Fluorophore. J. Org. Chem. 2002;67:910\u2013915. doi: 10.1021/jo016140o.", "ArticleIdList": ["10.1021/jo016140o", "11856036"]}, {"Citation": "Drzewiecka A., Koziol A.E., Borowski P., Sanna G., Giliberti G., La Colla P., Zawadowski T., Struga M. Structural and Antivirial Studies of Dipetalactone and Its Methyl Derivative. J. Mol. Struct. 2013;1054\u20131055:150\u2013156. doi: 10.1016/j.molstruc.2013.09.020.", "ArticleIdList": ["10.1016/j.molstruc.2013.09.020"]}, {"Citation": "Kasralikar H.M., Jadhavar S.C., Bhusare S.R. Synthesis and Molecular Docking Study of Novel Chromeno-Chromenones as Anti-HIV-1 NNRT Inhibitors. Synlett. 2015;26:1969\u20131972. doi: 10.1002/chin.201603141.", "ArticleIdList": ["10.1002/chin.201603141"]}, {"Citation": "Kasralikar H.M., Jadhavar S.C., Bhusare S.R. Synthesis and Molecular Docking Studies of Oxochromenyl Xanthenone and Indolyl Xanthenone Derivatives as Anti-HIV-1 RT Inhibitors. Bioorg. Med. Chem. Lett. 2015;25:3882\u20133886. doi: 10.1016/j.bmcl.2015.07.050.", "ArticleIdList": ["10.1016/j.bmcl.2015.07.050", "26243372"]}, {"Citation": "Rashamuse T.J., Klein R., Kaye P.T. Synthesis of Baylis-Hillman-Derived Phosphonated 3-(Benzylaminomethyl) Coumarins. Synth. Commun. 2010;40:3683\u20133690. doi: 10.1080/00397910903531649.", "ArticleIdList": ["10.1080/00397910903531649"]}, {"Citation": "Chalkha M., Nakkabi A., Ben Hadda T., Berredjem M., El Moussaoui A., Bakhouch M., Saadi M., El Ammari L., Almalki F.A., Laaroussi H., et al. Crystallographic Study, Biological Assessment and POM/Docking Studies of Pyrazoles-Sulfonamide Hybrids (PSH): Identification of a Combined Antibacterial/Antiviral Pharmacophore Sites Leading to in-Silico Screening the Anti-COVID-19 Activity. J. Mol. Struct. 2022;1267:133605. doi: 10.1016/j.molstruc.2022.133605.", "ArticleIdList": ["10.1016/j.molstruc.2022.133605", "PMC9237569", "35782312"]}, {"Citation": "Lakhrissi Y., Rbaa M., Tuzun B., Hichar A., Anouar E.H., Ounine K., Almalki F., Ben Hadda T., Zarrouk A., Lakhrissi B. Synthesis, Structural Confirmation, Antibacterial Properties and Bio-Informatics Computational Analyses of New Pyrrole Based on 8-Hydroxyquinoline. J. Mol. Struct. 2022;1259:132683. doi: 10.1016/j.molstruc.2022.132683.", "ArticleIdList": ["10.1016/j.molstruc.2022.132683"]}, {"Citation": "Rbaa M., Haida S., Tuzun B., Hichar A., El Hassane A., Kribii A., Lakhrissi Y., Ben Hadda T., Zarrouk A., Lakhrissi B., et al. Synthesis, Characterization and Bioactivity of Novel 8-Hydroxyquinoline Derivatives: Experimental, Molecular Docking, DFT and POM Analyses. J. Mol. Struct. 2022;1258:132688. doi: 10.1016/j.molstruc.2022.132688.", "ArticleIdList": ["10.1016/j.molstruc.2022.132688"]}, {"Citation": "Esharkawy E.R., Almalki F., Ben Hadda T. In Vitro Potential Antiviral SARS-CoV-19- Activity of Natural Product Thymohydroquinone and Dithymoquinone from Nigella Sativa. Bioorg. Chem. 2022;120:105587. doi: 10.1016/j.bioorg.2021.105587.", "ArticleIdList": ["10.1016/j.bioorg.2021.105587", "PMC8719923", "35026560"]}, {"Citation": "Titi A., Messali M., Alqurashy B.A., Touzani R., Shiga T., Oshio H., Fettouhi M., Rajabi M., Almalki F.A., Ben Hadda T. Synthesis, Characterization, X-Ray Crystal Study and Bioctivities of Pyrazole Derivatives: Identification of Antitumor, Antifungal and Antibacterial Pharmacophore Sites. J. Mol. Struct. 2020;1205:127625. doi: 10.1016/j.molstruc.2019.127625.", "ArticleIdList": ["10.1016/j.molstruc.2019.127625"]}, {"Citation": "Alawadi D.Y., Saadeh H.A., Kaur H., Goyal K., Sehgal R., Ben Hadda T., Elsawy N.A., Mubarak M.S. Metronidazole Derivatives as a New Class of Antiparasitic Agents: Synthesis, Prediction of Biological Activity, and Molecular Properties. Med. Chem. Res. 2015;24:1196\u20131209. doi: 10.1007/s00044-014-1197-4.", "ArticleIdList": ["10.1007/s00044-014-1197-4"]}, {"Citation": "Lahsasni S., Ben Hadda T., Masand V., Pathan N.B., Parvez A., Warad I., Shaheen U., Bader A., Aljofan M. POM Analyses of Raltegravir Derivatives: A New Reflection Enlightening the Mechanism of HIV-Integrase Inhibition. Res. Chem. Intermed. 2015;41:5121\u20135136. doi: 10.1007/s11164-014-1616-7.", "ArticleIdList": ["10.1007/s11164-014-1616-7"]}, {"Citation": "Hakkou Z., Maciuk A., Leblais V., Bouanani N.E., Mekhfi H., Bnouham M., Aziz M., Ziyyat A., Rauf A., Ben Hadda T., et al. Antihypertensive and Vasodilator Effects of Methanolic Extract of Inula Viscosa: Biological Evaluation and POM Analysis of Cynarin, Chlorogenic Acid as Potential Hypertensive. Biomed. Pharmacother. 2017;93:62\u201369. doi: 10.1016/j.biopha.2017.06.015.", "ArticleIdList": ["10.1016/j.biopha.2017.06.015", "28623784"]}, {"Citation": "Ben Hadda T., Khardli F.Z., Mimouni M., Daoudi M., Kerbal A., Salgado-Zamora H., Gandhare N., Parvez A., Lahsasni S. Impact of Geometric Parameters, Charge, and Lipophilicity on Bioactivity of Armed Quinoxaline, Benzothiaole, and Benzothiazine: Pom Analyses of Antibacterial and Antifungal Activity. Phosphorus Sulfur Silicon Relat. Elem. 2014;189:753\u2013761. doi: 10.1080/10426507.2013.855763.", "ArticleIdList": ["10.1080/10426507.2013.855763"]}, {"Citation": "Rachedi K.O., Ouk T.S., Bahadi R., Bouzina A., Djouad S.E., Bechlem K., Zerrouki R., Ben Hadda T., Almalki F., Berredjem M. Synthesis, DFT and POM Analyses of Cytotoxicity Activity of \u03b1-Amidophosphonates Derivatives: Identification of Potential Antiviral O,O-Pharmacophore Site. J. Mol. Struct. 2019;1197:196\u2013203. doi: 10.1016/j.molstruc.2019.07.053.", "ArticleIdList": ["10.1016/j.molstruc.2019.07.053"]}, {"Citation": "Berredjem M., Bouzina A., Bahadi R., Bouacida S., Rastija V., Djouad S.E., Sothea T.O., Almalki F.A., Ben Hadda T., Aissaoui M. Antitumor Activity, X-Ray Crystallography, in Silico Study of Some-Sulfamido-Phosphonates. Identification of Pharmacophore Sites. J. Mol. Struct. 2022;1250:131886. doi: 10.1016/j.molstruc.2021.131886.", "ArticleIdList": ["10.1016/j.molstruc.2021.131886"]}, {"Citation": "Ben Hadda T., Berredjem M., Almalki F.A., Rastija V., Jamalis J., Bin Emran T., Abu-Izneid T., Esharkawy E., Rodriguez L.C., Alqahtani A.M. How to Face COVID-19: Proposed Treatments Based on Remdesivir and Hydroxychloroquine in the Presence of Zinc Sulfate. Docking/DFT/POM Structural Analysis. J. Biomol. Struct. Dyn. 2022;40:9429\u20139442. doi: 10.1080/07391102.2021.1930161.", "ArticleIdList": ["10.1080/07391102.2021.1930161", "PMC8171014", "34033727"]}, {"Citation": "Mabkhot Y.N., Alatibi F., El-Sayed N.N.E., Al-Showiman S., Kheder N.A., Wadood A., Rauf A., Bawazeer S., Ben Hadda T. Antimicrobial Activity of Some Novel Armed Thiophene Derivatives and Petra/Osiris/Molinspiration (POM) Analyses. Molecules. 2016;21:222. doi: 10.3390/molecules21020222.", "ArticleIdList": ["10.3390/molecules21020222", "PMC6273311", "26901173"]}, {"Citation": "Bhat A.R., Dongre R.S., Almalki F.A., Berredjem M., Aissaoui M., Touzani R., Ben Hadda T., Akhter M.S. Synthesis, Biological Activity and POM/DFT/Docking Analyses of Annulated Pyrano[2,3-d]Pyrimidine Derivatives: Identification of Antibacterial and Antitumor Pharmacophore Sites. Bioorg. Chem. 2021;106:104480. doi: 10.1016/j.bioorg.2020.104480.", "ArticleIdList": ["10.1016/j.bioorg.2020.104480", "33279245"]}, {"Citation": "Chalkha M., Bakhouch M., Akhazzane M., Bourass M., Nicolas Y., Al Houari G., El Yazidi M. Design, Synthesis and Characterization of Functionalized Pyrazole Derivatives Bearing Amide and Sulfonamide Moieties from Aza-Aurones. J. Chem. Sci. 2020;132:86. doi: 10.1007/s12039-020-01792-3.", "ArticleIdList": ["10.1007/s12039-020-01792-3"]}, {"Citation": "Taneja S.C., Uhar K.L., Atal C.K. A Novel Ring Opening of Coumarins. Synth. Commun. 1980;10:37\u201342. doi: 10.1080/00397918008080051.", "ArticleIdList": ["10.1080/00397918008080051"]}, {"Citation": " [(accessed on 4 July 2023)].  Available online:  https://Www.maroc.ma/fr/actualites/research-excellence-awards-une-vingtaine-de-travaux-de-recherche-et-dinnovation-primes."}, {"Citation": "Ben Hadda T. Ranking 2023- Taibi BEN HADDA. 2022.  [(accessed on 4 July 2023)].  Available online:  https://www.adscientificindex.com/scientist/taibi-ben-hadda/91200."}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "9", "Day": "12"}, {"Year": "2023", "Month": "10", "Day": "18"}, {"Year": "2023", "Month": "10", "Day": "27"}, {"Year": "2023", "Month": "11", "Day": "25", "Hour": "12", "Minute": "45"}, {"Year": "2023", "Month": "11", "Day": "25", "Hour": "12", "Minute": "44"}, {"Year": "2023", "Month": "11", "Day": "25", "Hour": "1", "Minute": "21"}, {"Year": "2023", "Month": "10", "Day": "31"}], "PublicationStatus": "epublish", "ArticleIdList": ["38004404", "PMC10675815", "10.3390/ph16111538", "ph16111538"]}}], "PubmedBookArticle": []}